Diagnosis of hepatic veno-occlusive disease by plasminogen activator inhibitor-1 plasma antigen levels: A prospective analysis in 350 allogeneic hematopoietic stem cell recipients

Transplantation

Volumn 80, Issue 10, 2005, Pages 1376-1382

  Pihusch, Markus ^a   Wegner, Holger ^b   Goehring, Peter ^b   Salat, Christoph ^b   Pihusch, Verena ^b   Hiller, Erhard ^b   Andreesen, Reinhard ^a   Kolb, Hans Jochem ^b,c   Holler, Ernst ^a   Pihusch, Rudolf ^b  

^a UNIVERSITY HOSPITAL REGENSBURG   (Germany)

^b LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

^c INSTITUTE OF EPIDEMIOLOGY   (Germany)

Author keywords

Hematopoietic stem cell transplantation; Plasminogen activator inhibitor 1; Veno occlusive disease

Indexed keywords

ACICLOVIR; AMSACRINE; ANTIBIOTIC AGENT; BIOLOGICAL MARKER; BUSULFAN; CYCLOPHOSPHAMIDE; CYCLOSPORIN A; CYTARABINE; FLUDARABINE; METHOTREXATE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PLASMINOGEN ACTIVATOR INHIBITOR 1; PREDNISOLONE; THYMOCYTE ANTIBODY;

ADOLESCENT; ADULT; AGED; ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION; ANTIGEN DETECTION; ARTICLE; CHEMOTHERAPY; CLINICAL TRIAL; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; FEMALE; FEVER; GRAFT VERSUS HOST REACTION; HERPES SIMPLEX; HUMAN; HYPERBILIRUBINEMIA; IMMUNOSUPPRESSIVE TREATMENT; INFECTION; JAUNDICE; LIVER VEIN OBSTRUCTION; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; RECIPIENT; REDUCED INTENSITY CONDITIONING; SENSITIVITY AND SPECIFICITY; SEPSIS; SEPTIC SHOCK; THROMBOTIC THROMBOCYTOPENIC PURPURA; WHOLE BODY RADIATION;

ADOLESCENT; ADULT; AGED; ANEMIA, HEMOLYTIC; FEMALE; GRAFT VS HOST DISEASE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HEPATIC VENO-OCCLUSIVE DISEASE; HUMANS; INFECTION; MALE; MIDDLE AGED; PLASMINOGEN ACTIVATOR INHIBITOR 1; PROSPECTIVE STUDIES; TRANSPLANTATION CONDITIONING;

EID: 29144463571     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.tp.0000183288.67746.44     Document Type: Article

References (33)

1. Wadleigh M, Ho V, Momtaz P, Richardson P. Hepatic veno-occlusive disease: pathogenesis, diagnosis and treatment. Curr Opin Hematol 2003; 10: 451.
2. Jones RJ, Lee KS, Beschorner WE, et al. Venoocclusive disease of the liver following bone marrow transplantation. Transplantation 1987; 44: 778.
3. McDonald GB, Hinds MS, Fisher LD, et al. Veno-occlusive disease of the liver and multiorgan failure after bone marrow transplantation: a cohort study of 355 patients. Ann Intern Med 1993; 118: 255.
4. Salat C, Holler E, Kolb HJ, et al. Plasminogen Activator Inhibitor-1 confirms the diagnosis of hepatic veno-occlusive disease in patients with hyperbilirubinemia after bone marrow transplantation. Blood 1997; 89: 2184.
5. Richardson PG, Murakami C, Jin Z, et al. Multi-institutional use of defibrotide in 88 patients after stem cell transplantation with severe veno-occlusive disease and multisystem organ failure: response without significant toxicity in a high-risk population and factors predictive of outcome. Blood 2002; 100: 4337.
6. Salat C, Holler E, Kolb HJ, et al. The relevance of plasminogen activator inhibitor-1 (PAI-1) as a marker for the diagnosis of hepatic veno-occlusive disease in patients after bone marrow transplantation. Leuk Lymphoma 1999; 33: 25.
7. Salat C, Holler E, Reinhardt B, et al. Parameters of the fibrinolytic system in patients undergoing bone marrow transplantaion: Elevation of PAI-1 in veno-occlusive disease. Bone Marrow Transplant 1994; 14: 747.
8. Glucksberg H, Storb R, Fefer A, et al. Clinical manifestations of graft-versus-host disease in human recipients of marrow from HL-A-matched sibling donors. Transplantation 1974; 18: 295.
9. Shulman Shulman HM, Sullivan KM, Weiden PL, et al. Chronic graft-versus-host syndrome in man. A long-term clinicopathologic suty of 20 Seattle patients. Am J Med 1980; 69: 204.
10. Holler E, Kolb HJ, Hiller E, et al. Microangiopathy in patients on cyclosporine prophylaxis who developed acute graft-versus-host disease after HLA-identical bone marrow transplantation. Blood. 1989; 73: 2018.
11. Zeigler ZR, Shadduck RK, Nemunaitis J, et al. Bone marrow transplant-associated thrombotic microangiopathy: a case series. Bone Marrow Transplant 1995; 15: 247.
12. Misra S, Ament ME, Vargas JH, et al. Chronic liver disease in children on long-term parenteral nutrition. J Gastroenterol Hepatol 1996; 11: S4.
13. Herbetko J, Grigg AP, Buckley AR, Phillips GL. Venoocclusive liver disease after bone marrow transplantation: findings at duplex sonography. Am J Roentgenol 1992; 158: 1001.
14. Shulman HM, Gooley T, Dudley MD, et al. Utility of transvenous liver biopsies and wedged hepatic venous pressure measurements in sixty marrow transplant recipients. Transplantation 1995; 59: 1015.
15. Park YD, Yasui M, Yoshimoto T, et al. Changes in hemostatic parameters in hepatic veno-occlusive disease following bone marrow transplantation. Bone Marrow Transplant 1997; 19: 915.
16. Kruithof EKO. Plasminogen activator inhibitors - a review. Enzyme 1988; 40: 113.
17. Reilly TM, Mousa SA, Seetharam R, Racanelli AL. Recombinant plasminogen activator inhibitor type 1: a review of structural, functional, and biological aspects. Blood Coagul Fibrinolysis 1994; 5: 73.
18. Pihusch M, Lohse P, Reitberger J, et al. Impact of thrombophilic gene mutations and graft-versus-host disease on thromboembolic complications after allogeneic hematopoietic stem-cell transplantation. Transplantation 2004; 78: 911.
19. Eissner G, Multhoft G, Gerbitz A, et al. Fludarabine induces apoptosis, activation, and allogenicity in human endothelial and epithelial cells: protective effect of defibrotide. Blood 2002; 100: 334.
20. Moscardo F, Urbano-Ispizua A, Sanz GF, et al. Positive selection for CD34+ reduces the incidence and severity of veno-occlusive disease of the liver after HLA-identical sibling allogeneic peripheral blood stem cell transplantation. Exp Hematol 2003; 31: 545.
21. Chalandon Y, Roosnek E, Mermillod B, et al. Prevention of veno-occlusive disease with defibrotide after allogeneic stem cell transplantation. Biol Blood Marrow Transplant 2004; 10: 347.
22. Corbacioglu S, Greil J, Peters C, et al. Defibrotide in the treatment of children with veno-occlusive disease (VOD): a retrospective multicentre study demonstrates therapeutic efficacy upon early intervention. Bone Marrow Transplant 2004; 33: 189.
23. Imai A, Sugiyama M, Furui T, et al. Gonadotropin-releasing hormones agonist therapy increases peritoneal fibrinolytic activity and prevents adhesion formation after myomectomy. J Obstet Gynaecol 2003; 23: 660.
24. de Boer JP, Creasy AA, Chang A, et al. Activation patterns of coagulation and fibrinolysis in baboons following infusion with lethal or sublethal dose of Escherichia coli. Circ Shock 1993; 39: 59.
25. Massignon D, Lepape A, Bienvenu J, et al. Coagulation/fibrinolysis balance in septic shock related to cytokines and clinical state. Haemostasis 1994; 24: 36.
26. Nuernberger W, Michelmann I, Burdach S, Goebel U. Endothelial dysfunction after bone marrow transplantation: Increase of soluble thrombomodulin and PAI-1 in patients with multiple transplant-related complications. Ann Hematol 1998; 76: 61.
27. Grochow LB. Busulfan disposition: the role of therapeutic monitoring in bone marrow transplantation induction regimens. Semin Oncol 1993; 20 (Suppl 4): 18.
28. Hassan Z, Hellstrom-Lindberg E, Alsadi S, et al. The effect of modulation of glutathione cellular content on busulphan-induced cytotoxicity on hematopoietic cells in vitro and in vivo. Bone Marrow Transplant 2002; 30: 141.
29. Slattery JT, Kalhorn TF, McDonald GB, et al. Conditioning regimen-dependent disposition of cyclophosphamide and hydroxycyclophosphamide in human marrow transplantation patients. J Clin Oncol 1996; 14: 1484.
30. Holler E, Kolb HJ, Moller A, et al. Increased serum levels of tumor necrosis factor alpha precede major complications of bone marrow transplantation. Blood 1990; 75: 1011.
31. Lee JH, Lee KH, Choi SJ, et al. Veno-occlusive disease of the liver after allogeneic bone marrow transplantation for severe aplastic anemia. Bone Marrow Transplant 2000; 26: 657.
32. Pihusch R, Salat C, Schmitt E, et al. Hemostatic complications in bone marrow transplantation: a Retrospective Analysis of 447 patients. Transplantation 2002; 74: 1303.
33. American College of Chest Physicians/Society of Critical Care Medicine Consensus Conference: definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. Crit Care Med 1992; 20: 864.